Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD) or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination

  • Haepatology and nutrition
  • Swine fever virus
  • Blood brain barrier and diseases

Related Conference of Vaccines for Immune Mediated Diseases

March 18-19, 2021

3rd World Conference on Vaccine and Immunology

Dubai, UAE
April 05-05, 2021

Tumor & Cancer Immunology and Pediatric-Oncology

Toronto, Canada
May 03-04, 2021

International Online Conference on Immunology

New York, USA
June 23-24, 2021

34th World Congress on Vaccines and Immunization

Osaka, Australia
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
October 14-15, 2021

13th Annual Conference on Cinical Immunology

Cape Town, Australia
October 14-15, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa

Vaccines for Immune Mediated Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in